🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate in a step-wise approach the diseas...
Status
Withdrawn
Location
WCCT
Start Date
2016-11-01
Trial ID
NCT02760615
Treatments Being Tested
This Phase II Small Business Technology Transfer Research (STTR) will deliv...
Status
Completed
Location
Ohio State University Medical Center
Start Date
2018-02-19
Trial ID
NCT02921776
This is a single-center, single-arm, open-label, self-controlled, phase I c...
Status
Completed
Location
West China Second University Hospital Ethics Committee
Start Date
2020-09-03
Trial ID
NCT05088174
Treatments Being Tested
The purpose of this study is to evaluate the pharmacokinetic characteristic...
Status
Completed
Location
Inha University Hospital
Start Date
2022-08-04
Trial ID
NCT05460364
The primary objective of this clinical study is to determine whether the in...
Status
Completed
Location
City of Hope Comprehensive Cancer Center
Start Date
2010-04
Trial ID
NCT01100619
Treatments Being Tested
The purpose of this study is to investigate the pharmacokinetic (PK) proper...
Status
Completed
Location
Quotient Clinical
Start Date
2014-08
Trial ID
NCT02260830
Treatments Being Tested
This study is being done to look at how tucatinib could affect the way othe...
Status
Completed
Location
Covance Clinical Research Unit
Start Date
2018-09-17
Trial ID
NCT03723395
Treatments Being Tested
Evaluate the use by the patient and his family and professional environment...
Status
Completed
Location
Pôle Saint Hélier
Start Date
2018-06-11
Trial ID
NCT03667456
Treatments Being Tested
This is the first study of pomaglumetad in humans using methamphetamine. Th...
Status
Terminated
Location
UCLA
Start Date
2017-08-01
Trial ID
NCT03106571
Treatments Being Tested
Investigation of the relative bioavailability of a single dose of BI 691751...
Status
Completed
Location
1334.10.1 Boehringer Ingelheim Investigational Site
Start Date
2014-01
Trial ID
NCT02044393
Treatments Being Tested